Half Title Page.
List of Contributors.
3: Rodents Model for Toxicity Testing and Biomarkers.
4: Minipig Models for Toxicity Testing and Biomarkers.
5: Nonhuman Primates in Preclinical Research.
6: Biomarkers of Toxicity in Zebrafish.
7: Caenorhabditis Elegans as a Model for Biomarkers of Diseases and Toxicities.
8: Alternative Animal Toxicity Testing and Biomarkers.
9: Toxicokinetic-toxicodynamic Modeling.
10: Systems Toxicity Biomarkers.
11: Central Nervous System Toxicity Biomarkers.
12: Peripheral Nervous System Toxicity Biomarkers.
13: Cardiovascular Toxicity Biomarkers.
14: Respiratory Toxicity Biomarkers.
15: Hepatic Toxicity Biomarkers.
16: Conventional and Emerging Renal Biomarkers.
17: Gastrointestinal Toxicity Biomarkers.
18: Biomarkers of Acute and Chronic Pancreatitis.
19: Skeletal Muscle Toxicity Biomarkers.
20: Dermal Toxicity Biomarkers.
21: Ocular Biomarkers in Diseases and Toxicities.
22: Biomarkers of Toxicity in Human Placenta.
23: Blood and Bone Marrow Toxicity Biomarkers.
24: Immunotoxicity Biomarkers.
25: Agents Toxicity Biomarkers.
27: Herbicides and Fungicides.
28: Polychlorinated Biphenyls, Polybrominated Biphenyls, and Brominated Flame Retardants.
29: Polycyclic Aromatic Hydrocarbons.
30: Bisphenol A.
33: Chemical and Biological Warfare Agents.
34: Freshwater Cyanotoxins.
36: Poisonous Plants.
37: Pharmaceuticals and Nutraceuticals Biomarkers.
38: Biomarkers of Drug Toxicity.
39: Biomarkers of Toxicity for Dietary Ingredients Contained in Dietary Supplements.
40: Nutriphenomics in Rodent Models: Impact of Dietary Choices on Toxicological Biomarkers.
41: Biomarkers of Petroleum Products and Mixtures Toxicity.
42: Biomarkers of Petroleum Products Toxicity.
43: Biomarkers of Chemical Mixture Toxicity.
44: Biomarkers of Radiation, Nanoparticles, and Carcinogenesis.
45: Biomarkers of Radiation Injury and Response.
46: Biomarker Analysis for Nanotoxicology.
47: Engineered Nanomaterials: Biomarkers of Exposure and Effect.
48: Epigenetic Biomarkers in Toxicology.
49: Genotoxicity Biomarkers: Molecular Basis of Genetic Variability and Susceptibility.
50: Risk Factors as Biomarkers of Susceptibility in Breast Cancer.
51: Pancreatic and Ovarian Cancer Biomarkers.
52: Prostate Cancer Biomarkers.
53: Biomonitoring Exposures to Carcinogens.
54: Special Topics.
55: Biomarkers of Alzheimer's Disease.
56: Biomarkers of Parkinson's Disease.
57: Cytoskeletal Disruption as a Biomarker of Developmental Neurotoxicity.
58: Biomarkers of Mitochondrial Dysfunction and Toxicity.
59: Biomarkers of Oxidative/nitrosative Stress and Neurotoxicity.
60: Citrulline: Pharmacological Perspectives and Role as a Biomarker in Diseases and Toxicities.
61: Pathological Biomarkers in Toxicology.
62: Applications of Biomarkers in Toxicology.
63: Biomarkers in Drug Safety Evaluation.
64: Membrane Transporters and Transporter Substrates as Biomarkers for Drug Pharmacokinetics, Pharmacodynamics, and Toxicity/adverse Events.
65: Biomarkers in Biomonitoring of Xenobiotics.
66: Biomarkers of Susceptibility: Pharmacogenomics and Toxicogenomics.
67: Biomarkers for Drugs of Abuse and Neuropsychiatric Disorders: Models and Mechanisms.
68: Microrna Expression as an Indicator of Tissue Toxicity.
69: Percellome Toxicogenomics Project as a Source of Biomarkers of Chemical Toxicity.
70: Transcriptomic Biomarkers in Safety and Risk Assessment of Chemicals.
71: Biomarkers in Computational Toxicology.
72: Biomarkers in Toxicology, Risk Assessment, and Environmental Chemical Regulations.